Global Cervical Cancer Endoscopic Devices Market (2019-2023): Companies are Focusing on Developing Portable Smart & Pocket Colposcopes - ResearchAndMarkets.com

DUBLIN--()--The "Global Cervical Cancer Endoscopic Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The cervical cancer endoscopic devices market will register a CAGR of almost 6% by 2023.

The increasing number of cervical cancer endoscopic device launches is one of the key factors that will trigger the market growth during the forecast period.

With the rising prevalence of cervical cancer, manufacturers are focusing on developing advanced diagnostic products which can improve the efficacy of cervical cancer diagnosis. Moreover, many companies are also focusing on developing portable and fixed cervical cancer endoscopic devices and are launching products in various economies.

Therefore, product approvals by regulatory departments and launch of products will help companies to increase product sales and grow product-related awareness, which will boost the market growth during the forecast period.

Increasing prevalence of cervical cancer

With the rising prevalence of cervical cancer, there has been a growing demand for smart colposcopes. The growing partnerships between manufacturers and end-users will boost the adoption of cervical cancer endoscopic devices.

Shortage of skilled professional

With the increasing number of cervical cancer cases, there is a growing need for skilled professionals. Hence, the shortage of skilled professionals can reduce the adoption of cervical cancer endoscopic devices.

Competitive Landscape

The market appears to be fragmented with the presence of several market players. The high cost of conventional colposcopes can negatively impact market growth, due to which companies are focusing on developing portable smart and pocket colposcopes which are available at low cost.

This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Key Players

  • Danaher
  • DYSIS Medical Ltd.
  • MobileODT
  • Olympus Corp.
  • The Cooper Companies Inc.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Comparison by product
  • Optical colposcopes - Market size and forecast 2018-2023
  • Digital colposcopes - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

  • Growing demand for smart and pocket cervical cancer endoscopic devices
  • Availabilty of funds for advanced product development
  • Growing preference for robotic-assisted gynecology surgeries

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Danaher
  • DYSIS Medical Ltd.
  • MobileODT
  • Olympus Corp.
  • The Cooper Companies Inc.

For more information about this report visit https://www.researchandmarkets.com/r/q5a1ab

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cervical Cancer Drugs , Endoscopy

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cervical Cancer Drugs , Endoscopy